Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial
Shinnosuke Yamaura et al · BMC · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Material complementario disponible
Resumen
Descripción general del contenido del recurso.
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, S. Y. E. (2026). Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial. https://doi.org/10.1186/s40780-026-00562-6
MLA
al, Shinnosuke Yamaura et. "Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial." 2026. https://doi.org/10.1186/s40780-026-00562-6.
Chicago
al, Shinnosuke Yamaura et. 2026. "Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial.". https://doi.org/10.1186/s40780-026-00562-6.
Harvard
al, S. Y. E. 2026, Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial, BMC, available at: https://doi.org/10.1186/s40780-026-00562-6 [Accessed 29 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial
- Autor / colaboradores
- Shinnosuke Yamaura et al
- Editorial
- BMC
- Año de publicación
- 2026
- ISSN
- 2055-0294
- ISSN
- 2055-0294
- Idioma
- eng
Materias
Explorá otros recursos relacionados a partir de estas materias.